Back
GlycoMimetics Vs. Cellectar Biosciences Industry Stock Comparison
Sell
13
GLYC
GlycoMimetics
Last Price:
0.26
Seasonality Move:
17.05%
Sell
46
CLRB
Cellectar Biosciences
Last Price:
3.07
Seasonality Move:
-8.1%
Sell
13
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.27. The Score for GLYC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- GLYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $3.07. The Score for CLRB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLYC is experiencing slight buying pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $3.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 20.19 | Sell |
Chaikin Money Flow: | -1004233 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.93 - 2.45) | Sell |
Bollinger Bands (100): | (1.89 - 3.29) | Sell |
CLRB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 40.37 | Sell |
Chaikin Money Flow: | -894627 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.04 - 3.5) | Sell |
Bollinger Bands (100): | (3.03 - 3.87) | Sell |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.83 | Sell |
20-day SMA: | 1.48 | Sell |
50-day SMA: | 2.26 | Sell |
200-day SMA: | 2.04 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 1.34 | Sell |
50-day EMA: | 1.98 | Sell |
200-day EMA: | 2.13 | Sell |
CLRB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.25 | Sell |
20-day SMA: | 3.18 | Sell |
50-day SMA: | 3.55 | Sell |
200-day SMA: | 2.85 | Buy |
8-day EMA: | 3.21 | Sell |
20-day EMA: | 3.27 | Sell |
50-day EMA: | 3.39 | Sell |
200-day EMA: | 3.03 | Buy |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.07 per share, an increase this year of $1.19 per share, and an increase next year of $1.06 per share.
GlycoMimetics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cellectar Biosciences Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |